nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidronic acid—ATP6V1A—nephron tubule—kidney cancer	0.0122	0.19	CbGeAlD
Etidronic acid—ATP6V1A—renal system—kidney cancer	0.0111	0.172	CbGeAlD
Etidronic acid—ATP6V1A—kidney—kidney cancer	0.0107	0.167	CbGeAlD
Etidronic acid—ATP6V1A—cortex of kidney—kidney cancer	0.0104	0.162	CbGeAlD
Etidronic acid—ATP6V1A—gonad—kidney cancer	0.00991	0.155	CbGeAlD
Etidronic acid—ATP6V1A—cardiac atrium—kidney cancer	0.0099	0.154	CbGeAlD
Etidronic acid—Zoledronate—CA2—kidney cancer	0.00891	0.521	CrCbGaD
Etidronic acid—Risedronate—PTGS2—kidney cancer	0.00434	0.254	CrCbGaD
Etidronic acid—Clodronate—PTGS2—kidney cancer	0.00387	0.226	CrCbGaD
Etidronic acid—Hypersensitivity—Temsirolimus—kidney cancer	0.00201	0.00219	CcSEcCtD
Etidronic acid—Hallucination—Vincristine—kidney cancer	0.00201	0.00219	CcSEcCtD
Etidronic acid—Muscle spasms—Sunitinib—kidney cancer	0.002	0.00218	CcSEcCtD
Etidronic acid—Alopecia—Dactinomycin—kidney cancer	0.002	0.00218	CcSEcCtD
Etidronic acid—Anaemia—Sorafenib—kidney cancer	0.002	0.00217	CcSEcCtD
Etidronic acid—Agranulocytosis—Gemcitabine—kidney cancer	0.00199	0.00217	CcSEcCtD
Etidronic acid—Angioedema—Sorafenib—kidney cancer	0.00198	0.00215	CcSEcCtD
Etidronic acid—Erythema—Dactinomycin—kidney cancer	0.00197	0.00214	CcSEcCtD
Etidronic acid—Arthritis—Capecitabine—kidney cancer	0.00196	0.00213	CcSEcCtD
Etidronic acid—Infection—Erlotinib—kidney cancer	0.00195	0.00212	CcSEcCtD
Etidronic acid—Leukopenia—Sorafenib—kidney cancer	0.00194	0.00211	CcSEcCtD
Etidronic acid—Pruritus—Temsirolimus—kidney cancer	0.00193	0.0021	CcSEcCtD
Etidronic acid—Anaemia—Sunitinib—kidney cancer	0.00192	0.00209	CcSEcCtD
Etidronic acid—Pancytopenia—Paclitaxel—kidney cancer	0.0019	0.00207	CcSEcCtD
Etidronic acid—Osteoarthritis—Capecitabine—kidney cancer	0.0019	0.00207	CcSEcCtD
Etidronic acid—Angioedema—Sunitinib—kidney cancer	0.0019	0.00207	CcSEcCtD
Etidronic acid—Diarrhoea—Temsirolimus—kidney cancer	0.00187	0.00203	CcSEcCtD
Etidronic acid—Leukopenia—Sunitinib—kidney cancer	0.00186	0.00203	CcSEcCtD
Etidronic acid—Arthropathy—Doxorubicin—kidney cancer	0.00186	0.00202	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00185	0.00202	CcSEcCtD
Etidronic acid—Arthralgia—Sorafenib—kidney cancer	0.00184	0.002	CcSEcCtD
Etidronic acid—Glossitis—Doxorubicin—kidney cancer	0.00184	0.002	CcSEcCtD
Etidronic acid—Paraesthesia—Vinblastine—kidney cancer	0.00183	0.00199	CcSEcCtD
Etidronic acid—Paraesthesia—Everolimus—kidney cancer	0.00183	0.00199	CcSEcCtD
Etidronic acid—Pruritus—Pazopanib—kidney cancer	0.00182	0.00198	CcSEcCtD
Etidronic acid—Anaemia—Dactinomycin—kidney cancer	0.00182	0.00198	CcSEcCtD
Etidronic acid—Erythema multiforme—Gemcitabine—kidney cancer	0.00181	0.00197	CcSEcCtD
Etidronic acid—Dyspepsia—Everolimus—kidney cancer	0.00179	0.00195	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00179	0.00194	CcSEcCtD
Etidronic acid—Alopecia—Vincristine—kidney cancer	0.00179	0.00194	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00177	0.00193	CcSEcCtD
Etidronic acid—Arthralgia—Sunitinib—kidney cancer	0.00177	0.00193	CcSEcCtD
Etidronic acid—Bone pain—Doxorubicin—kidney cancer	0.00177	0.00192	CcSEcCtD
Etidronic acid—Leukopenia—Dactinomycin—kidney cancer	0.00176	0.00192	CcSEcCtD
Etidronic acid—Diarrhoea—Pazopanib—kidney cancer	0.00176	0.00192	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Paclitaxel—kidney cancer	0.00175	0.00191	CcSEcCtD
Etidronic acid—Infection—Sorafenib—kidney cancer	0.00175	0.00191	CcSEcCtD
Etidronic acid—Constipation—Vinblastine—kidney cancer	0.00174	0.0019	CcSEcCtD
Etidronic acid—Constipation—Everolimus—kidney cancer	0.00174	0.00189	CcSEcCtD
Etidronic acid—Vomiting—Temsirolimus—kidney cancer	0.00174	0.00189	CcSEcCtD
Etidronic acid—Dyspepsia—Erlotinib—kidney cancer	0.00173	0.00188	CcSEcCtD
Etidronic acid—Rash—Temsirolimus—kidney cancer	0.00172	0.00188	CcSEcCtD
Etidronic acid—Dermatitis—Temsirolimus—kidney cancer	0.00172	0.00187	CcSEcCtD
Etidronic acid—Headache—Temsirolimus—kidney cancer	0.00171	0.00186	CcSEcCtD
Etidronic acid—Alopecia—Gemcitabine—kidney cancer	0.00169	0.00184	CcSEcCtD
Etidronic acid—Infection—Sunitinib—kidney cancer	0.00169	0.00184	CcSEcCtD
Etidronic acid—Gastritis—Capecitabine—kidney cancer	0.00169	0.00183	CcSEcCtD
Etidronic acid—Feeling abnormal—Vinblastine—kidney cancer	0.00168	0.00183	CcSEcCtD
Etidronic acid—Constipation—Erlotinib—kidney cancer	0.00168	0.00183	CcSEcCtD
Etidronic acid—Feeling abnormal—Everolimus—kidney cancer	0.00168	0.00182	CcSEcCtD
Etidronic acid—Erythema—Gemcitabine—kidney cancer	0.00167	0.00182	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Vinblastine—kidney cancer	0.00167	0.00182	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Everolimus—kidney cancer	0.00166	0.00181	CcSEcCtD
Etidronic acid—Discomfort—Dactinomycin—kidney cancer	0.00166	0.0018	CcSEcCtD
Etidronic acid—Asthma—Capecitabine—kidney cancer	0.00165	0.00179	CcSEcCtD
Etidronic acid—Vomiting—Pazopanib—kidney cancer	0.00164	0.00178	CcSEcCtD
Etidronic acid—Anaemia—Vincristine—kidney cancer	0.00163	0.00177	CcSEcCtD
Etidronic acid—Rash—Pazopanib—kidney cancer	0.00162	0.00177	CcSEcCtD
Etidronic acid—Nausea—Temsirolimus—kidney cancer	0.00162	0.00177	CcSEcCtD
Etidronic acid—Dermatitis—Pazopanib—kidney cancer	0.00162	0.00177	CcSEcCtD
Etidronic acid—Abdominal pain—Vinblastine—kidney cancer	0.00161	0.00176	CcSEcCtD
Etidronic acid—Headache—Pazopanib—kidney cancer	0.00161	0.00176	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00161	0.00175	CcSEcCtD
Etidronic acid—Abdominal pain—Everolimus—kidney cancer	0.00161	0.00175	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Erlotinib—kidney cancer	0.0016	0.00175	CcSEcCtD
Etidronic acid—Infection—Dactinomycin—kidney cancer	0.0016	0.00174	CcSEcCtD
Etidronic acid—Leukopenia—Vincristine—kidney cancer	0.00157	0.00171	CcSEcCtD
Etidronic acid—Pancytopenia—Capecitabine—kidney cancer	0.00156	0.0017	CcSEcCtD
Etidronic acid—Cramps of lower extremities—Doxorubicin—kidney cancer	0.00155	0.00169	CcSEcCtD
Etidronic acid—Dyspepsia—Sorafenib—kidney cancer	0.00155	0.00169	CcSEcCtD
Etidronic acid—Abdominal pain—Erlotinib—kidney cancer	0.00155	0.00169	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00155	0.00168	CcSEcCtD
Etidronic acid—Oesophagitis—Doxorubicin—kidney cancer	0.00155	0.00168	CcSEcCtD
Etidronic acid—Anaemia—Gemcitabine—kidney cancer	0.00154	0.00168	CcSEcCtD
Etidronic acid—Rash maculo-papular—Doxorubicin—kidney cancer	0.00154	0.00167	CcSEcCtD
Etidronic acid—Nausea—Pazopanib—kidney cancer	0.00153	0.00166	CcSEcCtD
Etidronic acid—Paraesthesia—Sunitinib—kidney cancer	0.00152	0.00166	CcSEcCtD
Etidronic acid—Erythema multiforme—Paclitaxel—kidney cancer	0.00152	0.00165	CcSEcCtD
Etidronic acid—Constipation—Sorafenib—kidney cancer	0.00151	0.00164	CcSEcCtD
Etidronic acid—Hypersensitivity—Vinblastine—kidney cancer	0.0015	0.00164	CcSEcCtD
Etidronic acid—Hypersensitivity—Everolimus—kidney cancer	0.0015	0.00163	CcSEcCtD
Etidronic acid—Dyspepsia—Sunitinib—kidney cancer	0.00149	0.00163	CcSEcCtD
Etidronic acid—Leukopenia—Gemcitabine—kidney cancer	0.00149	0.00163	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00146	0.00159	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00145	0.00158	CcSEcCtD
Etidronic acid—Constipation—Sunitinib—kidney cancer	0.00145	0.00158	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Sorafenib—kidney cancer	0.00144	0.00157	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Capecitabine—kidney cancer	0.00144	0.00157	CcSEcCtD
Etidronic acid—Pruritus—Everolimus—kidney cancer	0.00144	0.00157	CcSEcCtD
Etidronic acid—Infection—Vincristine—kidney cancer	0.00143	0.00155	CcSEcCtD
Etidronic acid—Arthralgia—Gemcitabine—kidney cancer	0.00142	0.00155	CcSEcCtD
Etidronic acid—Alopecia—Paclitaxel—kidney cancer	0.00142	0.00154	CcSEcCtD
Etidronic acid—Discomfort—Gemcitabine—kidney cancer	0.0014	0.00153	CcSEcCtD
Etidronic acid—Urticaria—Sorafenib—kidney cancer	0.0014	0.00153	CcSEcCtD
Etidronic acid—Erythema—Paclitaxel—kidney cancer	0.0014	0.00152	CcSEcCtD
Etidronic acid—Diarrhoea—Vinblastine—kidney cancer	0.0014	0.00152	CcSEcCtD
Etidronic acid—Abdominal pain—Sorafenib—kidney cancer	0.00139	0.00152	CcSEcCtD
Etidronic acid—Diarrhoea—Everolimus—kidney cancer	0.00139	0.00151	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Sunitinib—kidney cancer	0.00139	0.00151	CcSEcCtD
Etidronic acid—Pruritus—Erlotinib—kidney cancer	0.00139	0.00151	CcSEcCtD
Etidronic acid—Flatulence—Paclitaxel—kidney cancer	0.00138	0.0015	CcSEcCtD
Etidronic acid—Agranulocytosis—Capecitabine—kidney cancer	0.00137	0.00149	CcSEcCtD
Etidronic acid—Infection—Gemcitabine—kidney cancer	0.00135	0.00147	CcSEcCtD
Etidronic acid—Muscle spasms—Paclitaxel—kidney cancer	0.00134	0.00146	CcSEcCtD
Etidronic acid—Abdominal pain—Sunitinib—kidney cancer	0.00134	0.00146	CcSEcCtD
Etidronic acid—Diarrhoea—Erlotinib—kidney cancer	0.00134	0.00146	CcSEcCtD
Etidronic acid—Feeling abnormal—Dactinomycin—kidney cancer	0.00132	0.00144	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00131	0.00143	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00131	0.00142	CcSEcCtD
Etidronic acid—Hypersensitivity—Sorafenib—kidney cancer	0.0013	0.00141	CcSEcCtD
Etidronic acid—Vomiting—Vinblastine—kidney cancer	0.0013	0.00141	CcSEcCtD
Etidronic acid—Vomiting—Everolimus—kidney cancer	0.00129	0.00141	CcSEcCtD
Etidronic acid—Anaemia—Paclitaxel—kidney cancer	0.00129	0.00141	CcSEcCtD
Etidronic acid—Paraesthesia—Vincristine—kidney cancer	0.00129	0.0014	CcSEcCtD
Etidronic acid—Rash—Everolimus—kidney cancer	0.00128	0.00139	CcSEcCtD
Etidronic acid—Dermatitis—Everolimus—kidney cancer	0.00128	0.00139	CcSEcCtD
Etidronic acid—Headache—Vinblastine—kidney cancer	0.00128	0.00139	CcSEcCtD
Etidronic acid—Angioedema—Paclitaxel—kidney cancer	0.00128	0.00139	CcSEcCtD
Etidronic acid—Headache—Everolimus—kidney cancer	0.00127	0.00139	CcSEcCtD
Etidronic acid—Abdominal pain—Dactinomycin—kidney cancer	0.00127	0.00138	CcSEcCtD
Etidronic acid—Leukopenia—Paclitaxel—kidney cancer	0.00125	0.00136	CcSEcCtD
Etidronic acid—Hypersensitivity—Sunitinib—kidney cancer	0.00125	0.00136	CcSEcCtD
Etidronic acid—Pruritus—Sorafenib—kidney cancer	0.00125	0.00136	CcSEcCtD
Etidronic acid—Vomiting—Erlotinib—kidney cancer	0.00125	0.00136	CcSEcCtD
Etidronic acid—Erythema multiforme—Capecitabine—kidney cancer	0.00125	0.00136	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00124	0.00135	CcSEcCtD
Etidronic acid—Rash—Erlotinib—kidney cancer	0.00124	0.00135	CcSEcCtD
Etidronic acid—Dermatitis—Erlotinib—kidney cancer	0.00124	0.00134	CcSEcCtD
Etidronic acid—Headache—Erlotinib—kidney cancer	0.00123	0.00134	CcSEcCtD
Etidronic acid—Constipation—Vincristine—kidney cancer	0.00123	0.00134	CcSEcCtD
Etidronic acid—Osteoarthritis—Doxorubicin—kidney cancer	0.00123	0.00134	CcSEcCtD
Etidronic acid—Paraesthesia—Gemcitabine—kidney cancer	0.00122	0.00133	CcSEcCtD
Etidronic acid—Nausea—Vinblastine—kidney cancer	0.00121	0.00132	CcSEcCtD
Etidronic acid—Nausea—Everolimus—kidney cancer	0.00121	0.00131	CcSEcCtD
Etidronic acid—Diarrhoea—Sorafenib—kidney cancer	0.00121	0.00131	CcSEcCtD
Etidronic acid—Pruritus—Sunitinib—kidney cancer	0.0012	0.00131	CcSEcCtD
Etidronic acid—Arthralgia—Paclitaxel—kidney cancer	0.00119	0.00129	CcSEcCtD
Etidronic acid—Hypersensitivity—Dactinomycin—kidney cancer	0.00118	0.00129	CcSEcCtD
Etidronic acid—Discomfort—Paclitaxel—kidney cancer	0.00118	0.00128	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Vincristine—kidney cancer	0.00117	0.00128	CcSEcCtD
Etidronic acid—Constipation—Gemcitabine—kidney cancer	0.00116	0.00127	CcSEcCtD
Etidronic acid—Nausea—Erlotinib—kidney cancer	0.00116	0.00127	CcSEcCtD
Etidronic acid—Alopecia—Capecitabine—kidney cancer	0.00116	0.00127	CcSEcCtD
Etidronic acid—Diarrhoea—Sunitinib—kidney cancer	0.00116	0.00126	CcSEcCtD
Etidronic acid—Confusional state—Paclitaxel—kidney cancer	0.00115	0.00125	CcSEcCtD
Etidronic acid—Erythema—Capecitabine—kidney cancer	0.00115	0.00125	CcSEcCtD
Etidronic acid—Abdominal pain—Vincristine—kidney cancer	0.00114	0.00124	CcSEcCtD
Etidronic acid—Infection—Paclitaxel—kidney cancer	0.00113	0.00123	CcSEcCtD
Etidronic acid—Flatulence—Capecitabine—kidney cancer	0.00113	0.00123	CcSEcCtD
Etidronic acid—Feeling abnormal—Gemcitabine—kidney cancer	0.00112	0.00122	CcSEcCtD
Etidronic acid—Vomiting—Sorafenib—kidney cancer	0.00112	0.00122	CcSEcCtD
Etidronic acid—Rash—Sorafenib—kidney cancer	0.00111	0.00121	CcSEcCtD
Etidronic acid—Dermatitis—Sorafenib—kidney cancer	0.00111	0.00121	CcSEcCtD
Etidronic acid—Headache—Sorafenib—kidney cancer	0.00111	0.0012	CcSEcCtD
Etidronic acid—Muscle spasms—Capecitabine—kidney cancer	0.0011	0.0012	CcSEcCtD
Etidronic acid—Diarrhoea—Dactinomycin—kidney cancer	0.0011	0.0012	CcSEcCtD
Etidronic acid—Gastritis—Doxorubicin—kidney cancer	0.00109	0.00118	CcSEcCtD
Etidronic acid—Vomiting—Sunitinib—kidney cancer	0.00108	0.00117	CcSEcCtD
Etidronic acid—Rash—Sunitinib—kidney cancer	0.00107	0.00117	CcSEcCtD
Etidronic acid—Dermatitis—Sunitinib—kidney cancer	0.00107	0.00116	CcSEcCtD
Etidronic acid—Headache—Sunitinib—kidney cancer	0.00106	0.00116	CcSEcCtD
Etidronic acid—Asthma—Doxorubicin—kidney cancer	0.00106	0.00115	CcSEcCtD
Etidronic acid—Anaemia—Capecitabine—kidney cancer	0.00106	0.00115	CcSEcCtD
Etidronic acid—Hypersensitivity—Vincristine—kidney cancer	0.00106	0.00115	CcSEcCtD
Etidronic acid—Nausea—Sorafenib—kidney cancer	0.00105	0.00114	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00104	0.00113	CcSEcCtD
Etidronic acid—Leukopenia—Capecitabine—kidney cancer	0.00103	0.00112	CcSEcCtD
Etidronic acid—Paraesthesia—Paclitaxel—kidney cancer	0.00102	0.00111	CcSEcCtD
Etidronic acid—Vomiting—Dactinomycin—kidney cancer	0.00102	0.00111	CcSEcCtD
Etidronic acid—Rash—Dactinomycin—kidney cancer	0.00101	0.0011	CcSEcCtD
Etidronic acid—Nausea—Sunitinib—kidney cancer	0.00101	0.0011	CcSEcCtD
Etidronic acid—Pancytopenia—Doxorubicin—kidney cancer	0.00101	0.0011	CcSEcCtD
Etidronic acid—Dyspepsia—Paclitaxel—kidney cancer	0.001	0.00109	CcSEcCtD
Etidronic acid—Diarrhoea—Vincristine—kidney cancer	0.000983	0.00107	CcSEcCtD
Etidronic acid—Arthralgia—Capecitabine—kidney cancer	0.000976	0.00106	CcSEcCtD
Etidronic acid—Constipation—Paclitaxel—kidney cancer	0.000975	0.00106	CcSEcCtD
Etidronic acid—Discomfort—Capecitabine—kidney cancer	0.000965	0.00105	CcSEcCtD
Etidronic acid—Pruritus—Gemcitabine—kidney cancer	0.000964	0.00105	CcSEcCtD
Etidronic acid—Nausea—Dactinomycin—kidney cancer	0.000955	0.00104	CcSEcCtD
Etidronic acid—Confusional state—Capecitabine—kidney cancer	0.000944	0.00103	CcSEcCtD
Etidronic acid—Feeling abnormal—Paclitaxel—kidney cancer	0.00094	0.00102	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000938	0.00102	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000933	0.00102	CcSEcCtD
Etidronic acid—Diarrhoea—Gemcitabine—kidney cancer	0.000932	0.00101	CcSEcCtD
Etidronic acid—Infection—Capecitabine—kidney cancer	0.00093	0.00101	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000927	0.00101	CcSEcCtD
Etidronic acid—Vomiting—Vincristine—kidney cancer	0.000913	0.000994	CcSEcCtD
Etidronic acid—Urticaria—Paclitaxel—kidney cancer	0.000906	0.000986	CcSEcCtD
Etidronic acid—Rash—Vincristine—kidney cancer	0.000905	0.000985	CcSEcCtD
Etidronic acid—Dermatitis—Vincristine—kidney cancer	0.000905	0.000985	CcSEcCtD
Etidronic acid—Abdominal pain—Paclitaxel—kidney cancer	0.000902	0.000981	CcSEcCtD
Etidronic acid—Headache—Vincristine—kidney cancer	0.0009	0.000979	CcSEcCtD
Etidronic acid—Agranulocytosis—Doxorubicin—kidney cancer	0.000883	0.000961	CcSEcCtD
Etidronic acid—Vomiting—Gemcitabine—kidney cancer	0.000866	0.000943	CcSEcCtD
Etidronic acid—Rash—Gemcitabine—kidney cancer	0.000859	0.000935	CcSEcCtD
Etidronic acid—Dermatitis—Gemcitabine—kidney cancer	0.000858	0.000934	CcSEcCtD
Etidronic acid—Headache—Gemcitabine—kidney cancer	0.000853	0.000929	CcSEcCtD
Etidronic acid—Nausea—Vincristine—kidney cancer	0.000853	0.000928	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000853	0.000928	CcSEcCtD
Etidronic acid—Paraesthesia—Capecitabine—kidney cancer	0.00084	0.000915	CcSEcCtD
Etidronic acid—Hypersensitivity—Paclitaxel—kidney cancer	0.00084	0.000915	CcSEcCtD
Etidronic acid—Dyspepsia—Capecitabine—kidney cancer	0.000824	0.000897	CcSEcCtD
Etidronic acid—Nausea—Gemcitabine—kidney cancer	0.000809	0.000881	CcSEcCtD
Etidronic acid—Pruritus—Paclitaxel—kidney cancer	0.000807	0.000878	CcSEcCtD
Etidronic acid—Erythema multiforme—Doxorubicin—kidney cancer	0.000803	0.000874	CcSEcCtD
Etidronic acid—Constipation—Capecitabine—kidney cancer	0.0008	0.000871	CcSEcCtD
Etidronic acid—Diarrhoea—Paclitaxel—kidney cancer	0.00078	0.000849	CcSEcCtD
Etidronic acid—Feeling abnormal—Capecitabine—kidney cancer	0.000771	0.000839	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Capecitabine—kidney cancer	0.000765	0.000833	CcSEcCtD
Etidronic acid—Alopecia—Doxorubicin—kidney cancer	0.00075	0.000817	CcSEcCtD
Etidronic acid—Urticaria—Capecitabine—kidney cancer	0.000744	0.000809	CcSEcCtD
Etidronic acid—Abdominal pain—Capecitabine—kidney cancer	0.00074	0.000805	CcSEcCtD
Etidronic acid—Erythema—Doxorubicin—kidney cancer	0.000739	0.000805	CcSEcCtD
Etidronic acid—Flatulence—Doxorubicin—kidney cancer	0.000728	0.000793	CcSEcCtD
Etidronic acid—Vomiting—Paclitaxel—kidney cancer	0.000725	0.000789	CcSEcCtD
Etidronic acid—Rash—Paclitaxel—kidney cancer	0.000719	0.000783	CcSEcCtD
Etidronic acid—Dermatitis—Paclitaxel—kidney cancer	0.000718	0.000782	CcSEcCtD
Etidronic acid—Headache—Paclitaxel—kidney cancer	0.000715	0.000778	CcSEcCtD
Etidronic acid—Muscle spasms—Doxorubicin—kidney cancer	0.000711	0.000774	CcSEcCtD
Etidronic acid—Hypersensitivity—Capecitabine—kidney cancer	0.00069	0.000751	CcSEcCtD
Etidronic acid—Anaemia—Doxorubicin—kidney cancer	0.000683	0.000744	CcSEcCtD
Etidronic acid—Nausea—Paclitaxel—kidney cancer	0.000677	0.000737	CcSEcCtD
Etidronic acid—Pruritus—Capecitabine—kidney cancer	0.000662	0.000721	CcSEcCtD
Etidronic acid—Leukopenia—Doxorubicin—kidney cancer	0.000662	0.00072	CcSEcCtD
Etidronic acid—Diarrhoea—Capecitabine—kidney cancer	0.00064	0.000697	CcSEcCtD
Etidronic acid—Arthralgia—Doxorubicin—kidney cancer	0.000629	0.000685	CcSEcCtD
Etidronic acid—Discomfort—Doxorubicin—kidney cancer	0.000622	0.000677	CcSEcCtD
Etidronic acid—Confusional state—Doxorubicin—kidney cancer	0.000608	0.000662	CcSEcCtD
Etidronic acid—Infection—Doxorubicin—kidney cancer	0.000599	0.000652	CcSEcCtD
Etidronic acid—Vomiting—Capecitabine—kidney cancer	0.000595	0.000648	CcSEcCtD
Etidronic acid—Rash—Capecitabine—kidney cancer	0.00059	0.000642	CcSEcCtD
Etidronic acid—Dermatitis—Capecitabine—kidney cancer	0.00059	0.000642	CcSEcCtD
Etidronic acid—Headache—Capecitabine—kidney cancer	0.000586	0.000638	CcSEcCtD
Etidronic acid—Nausea—Capecitabine—kidney cancer	0.000556	0.000605	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.00055	0.000598	CcSEcCtD
Etidronic acid—Paraesthesia—Doxorubicin—kidney cancer	0.000542	0.00059	CcSEcCtD
Etidronic acid—Dyspepsia—Doxorubicin—kidney cancer	0.000531	0.000578	CcSEcCtD
Etidronic acid—Constipation—Doxorubicin—kidney cancer	0.000516	0.000562	CcSEcCtD
Etidronic acid—Feeling abnormal—Doxorubicin—kidney cancer	0.000497	0.000541	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000493	0.000537	CcSEcCtD
Etidronic acid—Urticaria—Doxorubicin—kidney cancer	0.000479	0.000522	CcSEcCtD
Etidronic acid—Abdominal pain—Doxorubicin—kidney cancer	0.000477	0.000519	CcSEcCtD
Etidronic acid—Hypersensitivity—Doxorubicin—kidney cancer	0.000445	0.000484	CcSEcCtD
Etidronic acid—Pruritus—Doxorubicin—kidney cancer	0.000427	0.000465	CcSEcCtD
Etidronic acid—Diarrhoea—Doxorubicin—kidney cancer	0.000413	0.000449	CcSEcCtD
Etidronic acid—Vomiting—Doxorubicin—kidney cancer	0.000384	0.000418	CcSEcCtD
Etidronic acid—Rash—Doxorubicin—kidney cancer	0.00038	0.000414	CcSEcCtD
Etidronic acid—Dermatitis—Doxorubicin—kidney cancer	0.00038	0.000414	CcSEcCtD
Etidronic acid—Headache—Doxorubicin—kidney cancer	0.000378	0.000411	CcSEcCtD
Etidronic acid—Nausea—Doxorubicin—kidney cancer	0.000358	0.00039	CcSEcCtD
